Loading company
West Pharmaceutical Services Inc.
WST · NYSE · Healthcare · Medical Instruments and Supplies
Next earnings: October 22, 2026
$376.74+0.2%Sep 29 close
- 1M
- +11.6%
- 6M
- +53.9%
- 1Y
- +44.1%
- 5Y
- -13.6%
WST · NYSE · Healthcare · Medical Instruments and Supplies
Next earnings: October 22, 2026
$376.74+0.2%Sep 29 close
West Pharmaceutical Services Inc. is scheduled to report next on October 22, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $872.3M | $766.5M | +13.80% |
| Profit | $154M | $131.8M | +16.84% |
| Profit per share | $2.15 | $1.82 | +18.13% |
| Free Cash Flow | $80.8M | $101.9M | -20.71% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year. Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from West Pharmaceutical Services Inc.’s Item 2.02 8-K filed July 23, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
A short summary of each call — what the quarter showed, what management expects and whether they delivered on what they said last time — with the full transcript underneath.
Source: Yahoo Finance, transcribed by Quartr. Speaker names and roles are as transcribed; analysts are sometimes unnamed.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Call summaries are part of Pro
A two-minute read of every West Pharmaceutical Services Inc. earnings call: the numbers that mattered, what management expects, whether they delivered on last quarter’s outlook, and what analysts asked that went unanswered.
See one first on , , or — open to everyone.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.